106.961 articles found

The neurotoxic potential of isoquinoline derivatives structurally related to the Parkinsonism-inducing neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

McNaught KSP.

· 1996-01-01

An observation of density of N-methyl-D-aspartate receptors in striatum and mRNA level of N-methyl-D-aspartate receptors in substantia nigra of rats with Parkinson^s disease

Yang Hui, Zhang Kecheng, Cai Wenqin.

Di 3 jun yi da xue xue bao = Disanjunyidaxue xuebao = Acta Acadiemiae [i.e. Academiae] Medicinae Militaris Tertiae · 1996-01-01

The experiment of transgenic therapy for Parkinson disease in rat

Cao Lei, Jiang Qiong, Zheng Zhongcheng, Sun Lanying, Liu Xinyuan.

Sheng wu hua xue za zhi = Chinese biochemical journal · 1996-01-01

Simultaneous electromyography and manometry of the anal sphincters in parkinsonian patients: technical considerations.

Normand MM, Ashraf W, Quigley EM, Maurer KB, Edwards L, Pfeiffer RF, Wszolek ZK.

Muscle Nerve · 1996-01-01

PMID: 8538660

Prevalence of parkinsonian signs and associated mortality in a community population of older people.

Bennett DA, Beckett LA, Murray AM, Shannon KM, Goetz CG, Pilgrim DM, Evans DA.

N Engl J Med · 1996-01-01

DOI: 10.1056/nejm199601113340202PMID: 8531961

Living with Parkinson's disease.

Salzman EW.

N Engl J Med · 1996-01-01

DOI: 10.1056/nejm199601113340210PMID: 8531944

Iodine-123-iodo-lisuride SPECT in Parkinson's disease.

Cordes M, Hierholzer J, Schelosky L, Schrag A, Richter WS, Eichstädt H, Schulze PE, Poewe W, Felix R.

J Nucl Med · 1996-01-01

PMID: 8543995

A door-to-door survey of Parkinson's disease in a Chinese population in Kinmen.

Wang SJ, Fuh JL, Teng EL, Liu CY, Lin KP, Chen HM, Lin CH, Wang PN, Ting YC, Wang HC, Lin KN, Chou P, Larson EB, Liu HC.

Arch Neurol · 1996-01-01

DOI: 10.1001/archneur.1996.00550010084020PMID: 8599561

Moderate Parkinson's disease. Strategies for maximizing treatment.

Silverstein PM.

Postgrad Med · 1996-01-01

PMID: 8539210

ABT-431: the diacetyl prodrug of A-86929, a potent and selective dopamine D1 receptor agonist: in vitro characterization and effects in animal models of Parkinson's disease.

Shiosaki K, Jenner P, Asin KE, Britton DR, Lin CW, Michaelides M, Smith L, Bianchi B, Didomenico S, Hodges L, Hong Y, Mahan L, Mikusa J, Miller T, Nikkel A, Stashko M, Witte D, Williams M.

J Pharmacol Exp Ther · 1996-01-01

DOI: 10.1016/s0022-3565(25)12244-1PMID: 8558425

Neuroprotection in Parkinson's disease.

Montastruc JL, Rascol O, Senard JM.

Lancet · 1996-01-01

DOI: 10.1016/s0140-6736(96)90381-5PMID: 8544568

Parkinson's and Alzheimer's: new tools, new attitudes in patient care.

Jenkyn LR, Coffey DJ, Reeves AG.

Geriatrics · 1996-01-01

PMID: 8543200